besilate vs
MPFF295 reported similar and signiﬁcant pain reduction
in both groups. In an RCT vs placebo in patients with
CEAP C3-4,296 calcium dobesilate signiﬁcantly decreased
leg volume (P ¼ .0002) and improved symptoms
(discomfort, heavy legs, tired legs, tingling, itching and
cramps (P < .05).297
A meta